These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33026311)

  • 21. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
    Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
    J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paroxetine in social anxiety disorder: a randomized placebo-controlled study.
    Allgulander C
    Acta Psychiatr Scand; 1999 Sep; 100(3):193-8. PubMed ID: 10493085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study of gray matter volume changes associated with paroxetine treatment and response in social anxiety disorder.
    Talati A; Pantazatos SP; Hirsch J; Schneier F
    Psychiatry Res; 2015 Mar; 231(3):279-85. PubMed ID: 25659476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neurobiology and pharmacotherapy of social phobia].
    Aouizerate B; Martin-Guehl C; Tignol J
    Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.
    Strawn JR; Mills JA; Sauley BA; Welge JA
    J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):235-244.e2. PubMed ID: 29588049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac autonomic tone, plasma BDNF levels and paroxetine response in newly diagnosed patients of generalised anxiety disorder.
    Dutt R; Shankar N; Srivastava S; Yadav A; Ahmed RS
    Int J Psychiatry Clin Pract; 2020 Jun; 24(2):135-142. PubMed ID: 32022607
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and tolerability of paroxetine in adults with social anxiety disorder: A meta-analysis of randomized controlled trials.
    Li X; Hou Y; Su Y; Liu H; Zhang B; Fang S
    Medicine (Baltimore); 2020 Apr; 99(14):e19573. PubMed ID: 32243377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder.
    Seedat S; Stein MB
    J Clin Psychiatry; 2004 Feb; 65(2):244-8. PubMed ID: 15003080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
    Hilton RC; Rengasamy M; Mansoor B; He J; Mayes T; Emslie GJ; Porta G; Clarke GN; Wagner KD; Birmaher B; Keller MB; Ryan N; Shamseddeen W; Asarnow JR; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2013 May; 52(5):482-92. PubMed ID: 23622849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy for social anxiety disorder: Interpersonal predictors of outcome and the mediating role of the working alliance.
    Cohen JN; Drabick DAG; Blanco C; Schneier FR; Liebowitz MR; Heimberg RG
    J Anxiety Disord; 2017 Dec; 52():79-87. PubMed ID: 29102818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroxetine, Cognitive Therapy or Their Combination in the Treatment of Social Anxiety Disorder with and without Avoidant Personality Disorder: A Randomized Clinical Trial.
    Nordahl HM; Vogel PA; Morken G; Stiles TC; Sandvik P; Wells A
    Psychother Psychosom; 2016; 85(6):346-356. PubMed ID: 27744447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice.
    Collins HM; Pinacho R; Ozdemir D; Bannerman DM; Sharp T
    J Psychopharmacol; 2022 Jul; 36(7):794-805. PubMed ID: 35607713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiety, emotional security and the interpersonal behavior of individuals with social anxiety disorder.
    Russell JJ; Moskowitz DS; Zuroff DC; Bleau P; Pinard G; Young SN
    Psychol Med; 2011 Mar; 41(3):545-54. PubMed ID: 20459889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open trial of paroxetine for the "offensive subtype" of taijin kyofusho and social anxiety disorder.
    Nagata T; van Vliet I; Yamada H; Kataoka K; Iketani T; Kiriike N
    Depress Anxiety; 2006; 23(3):168-74. PubMed ID: 16456863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder.
    Frick A; Åhs F; Appel L; Jonasson M; Wahlstedt K; Bani M; Merlo Pich E; Bettica P; Långström B; Lubberink M; Fredrikson M; Furmark T
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1775-1783. PubMed ID: 27642077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder.
    Book SW; Thomas SE; Randall PK; Randall CL
    J Anxiety Disord; 2008; 22(2):310-8. PubMed ID: 17448631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
    Hudd TR; Blake CS; Rimola-Dejesus Y; Nguyen TT; Zaiken K
    J Pharm Pract; 2020 Apr; 33(2):206-212. PubMed ID: 31030620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers.
    Bell C; Wilson S; Rich A; Bailey J; Nutt D
    Psychopharmacology (Berl); 2003 Mar; 166(2):102-10. PubMed ID: 12536263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.